We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$206M
AUM Growth
+$80M
Cap. Flow
-$1.07M
Cap. Flow %
-0.52%
Top 10 Hldgs %
40.32%
Holding
148
New
41
Increased
22
Reduced
20
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 20.62%
2 Healthcare 12.27%
3 Consumer Discretionary 3.1%
4 Financials 2.19%
5 Industrials 1.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COHU icon
1
Cohu
COHU
$2.39B
$6.92M 3.36%
165,499
+18,528
+13% +$816K
AVNW icon
2
Aviat Networks
AVNW
$262M
$4.94M 2.39%
138,974
+20,210
+17% +$532K
EMKR
3
DELISTED
Emcore Corp
EMKR
$4.33M 2.1%
79,371
+20,788
+35% +$1.25M
TLND
4
DELISTED
Talend S.A. American Depositary Shares
TLND
$4.19M 2.03%
+65,800
New +$3.42M
OIIM
5
DELISTED
02Micro International
OIIM
$3.64M 1.76%
465,169
THER
6
DELISTED
THERATECHNOLOGIES INC COM
THER
$3.29M 1.6%
851,413
+705,251
+483% +$2.73M
ASPN icon
7
Aspen Aerogels
ASPN
$387M
$2.98M 1.45%
146,687
-22,354
-13% -$472K
DZSI
8
DELISTED
DZS Inc. Common Stock
DZSI
$2.65M 1.28%
+170,118
New +$2.83M
AVYA
9
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$2.59M 1.25%
92,279
-76,020
-45% -$2.03M
ADMS
10
DELISTED
Adamas Pharmaceuticals
ADMS
$2.58M 1.25%
538,395
+313,289
+139% +$1.64M
RMNI icon
11
Rimini Street
RMNI
$408M
$2.49M 1.21%
+277,555
New +$2.15M
PBYI icon
12
Puma Biotechnology
PBYI
$406M
$2.2M 1.07%
+226,758
New +$2.53M
FOCL
13
EDAP TMS S.A.
FOCL
$226M
$2.14M 1.04%
254,818
+153,736
+152% +$1.25M
SILC icon
14
Silicom
SILC
$228M
$2.05M 0.99%
45,427
-937
-2% -$43.8K
NVVE icon
15
Nuvve Holding Corp
NVVE
$1.93M 0.94%
+1
New +$4.72M
GRTX
16
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.89M 0.92%
+214,242
New +$2.35M
BWAY
17
Brainsway
BWAY
$641M
$1.61M 0.78%
+357,200
New +$1.55M
CDLX icon
18
Cardlytics
CDLX
$21M
$1.55M 0.75%
+1,413
New +$1.87M
OEF icon
19
PUT
iShares S&P 100 ETF
OEF
$19.8B
$1.54M 0.75%
164,900
+163,424
+11,072% +$28.8M
SBBP
20
DELISTED
Strongbridge Biopharma plc.
SBBP
$1.52M 0.74%
550,196
+101,150
+23% +$305K
ALLT icon
21
Allot
ALLT
$374M
$1.47M 0.71%
92,329
-19,411
-17% -$283K
LPTH icon
22
Lightpath Technologies
LPTH
$680M
$1.46M 0.71%
469,878
AIRG icon
23
Airgain
AIRG
$74.3M
$1.45M 0.7%
68,169
-59,936
-47% -$1.35M
BCOV
24
DELISTED
Brightcove, Inc.
BCOV
$1.43M 0.69%
70,984
+2,442
+4% +$49K
SCPH
25
DELISTED
scPharmaceuticals
SCPH
$1.42M 0.69%
214,060
+51,185
+31% +$351K

Similar funds

Worth Venture Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Worth Venture Partners held 148 positions worth $206M, up 63% from $126M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Worth Venture Partners's Q1 2021 filing shows 41 new, 22 increased, 20 reduced and 37 closed positions. Its largest new stake was Nuvve Holding Corp: 1 share worth $1.93M. The largest sale was Blue Bird Corp, an estimated $3.79M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Worth Venture Partners's largest Q1 2021 buy was Nuvve Holding Corp: 1 share worth $1.93M.
  • Worth Venture Partners added most to THERATECHNOLOGIES INC COM in Q1 2021, an estimated $2.73M increase.
  • Worth Venture Partners's biggest Q1 2021 reduction was Avaya Holdings Corp. Common Stock, cutting an estimated $2.03M.
  • Worth Venture Partners fully exited Blue Bird Corp in Q1 2021, selling an estimated $3.79M.
  • Worth Venture Partners's ten largest holdings make up 40% of its $206M portfolio in Q1 2021.
  • Worth Venture Partners opened 41 new positions and closed 37 in Q1 2021.
  • Worth Venture Partners's portfolio value rose 63% quarter-over-quarter to $206M.

Based on Worth Venture Partners's 13F filing for Q1 2021, filed 17 May 2021.